GMiA welcomes ‘a’ flagging of biosimilars

lots of tiny aspirin pills
The Generic Medicines Industry Association has welcomed the PBAC's decision to consider “a” flagging of biosimilars, and to list biosimilar insulin (Basaglar) on the PBS. Basaglar is the first biosimilar insulin to be approved in Australia, providing an alternative, affordable treatment option for patients suffering from diabetes. “Australian patients are now able to benefit from

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Complementary Medicines Australia launches seminar
Next SHPA welcomes Choosing Wisely decision